Skip to content

Outcome and Factors of Liver Disease

The Natural History and Prognostic Factors of Compensated Cirrhosis: An Ambi prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019775
Enrollment
166
Registered
2019-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Compensated Cirrhosis

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Institute of liver and Biliary Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age 18 to 75 years 2)Compensated cirrhosis 3)Biopsy proven cirrhosis or LSM > 12.5 Kpa.

Exclusion criteria

Exclusion criteria: 1) Any current or prior clinical decompesnation (ascites, jaundice, encephalopathy or gastrointestinal hemorrhage). 2) Pregnant Women 3) Hepatocellular Carcinoma 4) Known case of severe cardiopulmonary disease 5) Known case of severe Hepato Pulmonary Syndrome

Design outcomes

Primary

MeasureTime frame
Development of ascites, jaundice, encephalopathy or gastrointestinal hemorrhage) during the follow up period of 2 yeasTimepoint: 2 Years

Secondary

MeasureTime frame
Number of patients develop Hepatic osteodystrophy during follow up period of 2 years. Timepoint: 2 Year;Number of patients develop hepatocellular carcinoma (HCC) during follow up period 2 years. Timepoint: 2 Year;Number of patients develop Hypersplenism during follow up period of 2 years. Timepoint: 2 Year;Number of patients develop Minimal Hepatic Encephalopathy (MHE) during follow up period of 2 years. Timepoint: 2 Year;Number of patients develop Pulmonary Syndrome (HPS) during follow up period of 2 years. Timepoint: 2 Year;Patients with new onset/progression of esophageal varices during the period of 2 yearsTimepoint: 2 Years;Reduction in portal pressure with more than 20% from baseline at 1 yearTimepoint: 1 Year;Reduction in portal pressure with more than 20% from baseline at 2 year.Timepoint: 2 Year;Reduction in portal pressure with more than 20% from baseline at 6 monthsTimepoint: 6 Months;Survival during the period of 2 years.Timepoint: 2 Year

Countries

India

Contacts

Public ContactDr Ankit Bhardwaj

Institute of liver and Biliary Sciences

bhardwaj.ankit3@gmail.com011-46300000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026